You will have heard Tim O’Brien’s initiation lecture outlining his vision for his presidency last June, and at other times since, explaining the link between BAUS, TUF and the CHaRT research unit in Aberdeen to help promote the best opportunity for all UK Urologists to devise, design and deliver important research ideas that will change practice.
Undertaking large-scale, multicentre, randomised clinical trials is a complex process that requires professional support to design the study, comply with regulations, manage data collection, analyse results and understand the health impacts. Clinical Trials Units (CTUs) provide the necessary infrastructure to support such studies.
TUF has agreed to provide funding to CHaRT (Centre for Healthcare Randomised Trials), based in Aberdeen, to act as the CTU for Urological trials. CHaRT was the clinical trials unit that supported some of the world-leading randomised trials in stone disease management (SUSPEND, TISU and PuRE) led by Prof Sam McClinton.
This initiative will democratise access to trial support services for all urologists. NICE stone guidelines (2019) have highlighted some key unanswered questions that might be addressed. Urologists/patients may have other important questions in endourology that well-conducted trials could answer.
Submit your proposal before the end of April for consideration at a Dragon's den style competition at BAUS.
Click here for more information from TUF. This process is open to everyone, and part of the remit is to encourage and provide a framework for research to units that are not already associated with a research organisation. Please get in touch with Professor Ben Turney or Professor Caroline Moore for a steer in the right direction ... or register for the "So, you have an idea for a trial ... " webinar on 15 April at 19:00hr.